A retrospective look at 216 patients undergoing definitive resection of Brigham and Women’s stage T2b-3 cutaneous squamous cell carcinoma at none other than Brigham and Women’s suggests those receiving Moh resection (n=131) have better outcomes than those undergoing wide local excisions (n=85). After propensity matching, at 3 years, local recurrence was double with WLE (20%) than Mohs (10%). There were also significant differences in nodal mets (18% vs 11%), distant mets (8% versus 4%), and even disease-specific death (18% versus 7%). These rates are all quite high, and it appears none of these patients received adjuvant radiation. Ultimately, cutaneous squamous cell carcinoma with more than one risk factor such as these should be taken seriously and may optimally be managed with both sophisticated margin-control resection and adjuvant radiation—that latter already suggested by NCCN guidelines. | Wang, JAMA Dermatol 2025

